Myeloid cell interactions in atherosclerosis
动脉粥样硬化中的骨髓细胞相互作用
基本信息
- 批准号:9311933
- 负责人:
- 金额:$ 45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigen PresentationAortaApolipoprotein EAreaArterial Fatty StreakArteriesAtherosclerosisBehaviorBiological ModelsBromodeoxyuridineCell CommunicationCell ShapeCellsCessation of lifeCharacteristicsColorDancingDataDendritesEndothelial CellsEndotheliumExternal carotid artery structureFundingGene ExpressionGene Expression ProfileGenesGeneticHot SpotITGAM geneImageIn SituInflammationInjectableIntegrin alpha4beta1IntegrinsLabelLeukocytesLigandsMeasuresMethodsMicroscopyMinimally modified Low Density LipoproteinModernizationMolecularMolecular ProfilingMonoclonal AntibodiesMovementMusMutationMyeloid CellsMyocardial InfarctionNaturePatternPeripheral arterial diseasePhenotypePrimary PreventionProliferatingResearchSecondary PreventionSpottingsStrokeSurfaceTechnologyTestingTimeWorkbasecadherin 5cell typechemokinechemokine receptordeep sequencingdifferential expressionexperimental studygenome-wideimage processingimaging systemin vivointravital microscopylive cell imagingmacrophagemicroscopic imagingmigrationmonocytemovieoxidized low density lipoproteinprogramstooltranscriptometranscriptome sequencinguptake
项目摘要
Description
Although tremendous progress has been made in primary and secondary prevention, the complications of
atherosclerosis (heart attacks, strokes and peripheral artery disease) still account for the most deaths
worldwide. Here, we propose to test three hypotheses. This work has become possible through the intravital
live cell triggered imaging system (ILTIS) we developed in the current funding cycle. Hypothesis 1 is that non-
classical monocytes use LFA-1 (αLβ2 integrin) and ~40% also VLA-4 (α4β1 integrin) to patrol the endothelium
overlying atherosclerotic plaque. We have preliminary evidence for at least two subsets of patrolling monocytes
in atherosclerotic arteries. To test the molecular mechanism of patrolling, we will block integrins, their ligands,
chemokines and chemokine receptors using monoclonal antibodies. Hypothesis 2 is that blood monocytes gain
access to atherosclerotic plaque through the luminal endothelium. To test how monocytes enter atherosclerotic
lesions, we have made mice with yellow (YFP) endothelium that are crossed into the Apoe-/- atherosclerosis-
prone background. Combining these mice with mice in which monocyte subsets are fluorescently labeled
(Cx3cr1GFP/+ for non-classical, Ccr2RFP/+ for classical monocytes) will show transendothelial migration of
monocytes into atherosclerotic plaque in vivo. Hypothesis 3 is that four newly discovered plaque macrophage
subsets (by ILTIS) have different functions. Preliminary RNA-Seq data show that their gene expression profiles
vary significantly. We will test these functions: proliferation by BrdU and Ki67; oxLDL and minimally modified
(mm)LDL uptake; efferocytosis; migration and antigen presentation. When the proposed work is complete, we
will know, for the first time, how monocytes patrol atherosclerotic arteries, how they enter atherosclerotic
lesions and what they do there. We will identify key functions of the four newly discovered monocyte and
macrophage subsets in atherosclerotic plaque.
描述
尽管在预防初级和次要的预防中已经取得了巨大进展,但汇编的汇编
动脉粥样硬化(心脏病发作,中风和周围性抗疾病)仍然是死亡人数最多的
在世界范围内。
我们在当前的资金周期中开发的活细胞触发成像系统(ILTIS)。
经典的单核细胞使用LFA-1(αLβ2整合素)和〜40%的VLA-4(α4β1整合素)巡逻内皮
上覆盖的动植物斑块。
在动脉粥样硬化的动脉中。
使用单克隆抗体的趋化因子和趋化因子受体。
通过腔内皮细胞进入屈服斑块。
病变,我们已经用黄色(YFP)内皮变成了apoE - / - 动脉粥样硬化 -
俯卧的背景。
(对于非古典,CCR2RFP/+的CX3CR1GFP/+,用于经典单核细胞)将显示跨内皮迁移
单核细胞进入体内的动脉粥样硬化斑块。
子集(通过ILTIS)具有不同的功能。
我们将测试这些功能很大。
(MM)LDL摄取;
将首次知道单核细胞如何巡逻动脉粥样硬化动脉,如何进入动脉粥样硬化
病变,他们在那里做。
动脉粥样硬化斑块中的巨噬细胞子集。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Klaus F. Ley其他文献
Binding of function‐blocking mAbs to mouse and human P‐selectin glycoprotein ligand‐1 peptides with and without tyrosine sulfation
功能阻断单克隆抗体与小鼠和人 P-选择素糖蛋白配体 1 肽(有或没有酪氨酸硫酸化)的结合
- DOI:
- 发表时间:
2002 - 期刊:
- 影响因子:5.5
- 作者:
Aravinda Thatte;S. Ficarro;K. Snapp;M. Wild;D. Vestweber;D. Hunt;Klaus F. Ley - 通讯作者:
Klaus F. Ley
Klaus F. Ley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Klaus F. Ley', 18)}}的其他基金
Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
- 批准号:
10676897 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Mechanism of kindlin-3-dependent integrin activation
kindlin-3依赖性整合素激活机制
- 批准号:
10229369 - 财政年份:2020
- 资助金额:
$ 45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10112954 - 财政年份:2019
- 资助金额:
$ 45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10369710 - 财政年份:2019
- 资助金额:
$ 45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
9895858 - 财政年份:2019
- 资助金额:
$ 45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10623034 - 财政年份:2019
- 资助金额:
$ 45万 - 项目类别:
Vascular macrophages and T cells in atherosclerosis
动脉粥样硬化中的血管巨噬细胞和 T 细胞
- 批准号:
10565907 - 财政年份:2019
- 资助金额:
$ 45万 - 项目类别:
Core E: Cell sorting, CyTOF and RNA-Seq
核心 E:细胞分选、CyTOF 和 RNA-Seq
- 批准号:
10188604 - 财政年份:2017
- 资助金额:
$ 45万 - 项目类别:
Core B: Single Cell Protein and RNA Sequencing Core
核心 B:单细胞蛋白质和 RNA 测序核心
- 批准号:
10334092 - 财政年份:2017
- 资助金额:
$ 45万 - 项目类别:
相似国自然基金
运动模拟物Irisin通过抑制线粒体抗原呈递促进帕金森病康复的作用机制研究
- 批准号:82302860
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肝纤维化病程中CD36抑制巨噬细胞抗原呈递功能的作用研究
- 批准号:82370630
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
lncRNA介导的巨噬细胞抗原呈递功能在动脉粥样硬化中的作用及分子机制
- 批准号:32300996
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Optineurin抑制巨噬细胞抗原呈递缓解免疫介导性肝炎的分子机制研究
- 批准号:82273935
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
- 批准号:
10731402 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
Understanding how the interaction between Lag3 deficiency and hypercholesterolemia impact anti-tumor immunity and cardiovascular disease in a melanoma model
了解 Lag3 缺乏与高胆固醇血症之间的相互作用如何影响黑色素瘤模型中的抗肿瘤免疫和心血管疾病
- 批准号:
10637369 - 财政年份:2023
- 资助金额:
$ 45万 - 项目类别:
PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
- 批准号:
10282751 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
- 批准号:
10447208 - 财政年份:2021
- 资助金额:
$ 45万 - 项目类别:
Impact of the Adipose Tissue Microenvironment on Atherosclerosis
脂肪组织微环境对动脉粥样硬化的影响
- 批准号:
10063545 - 财政年份:2017
- 资助金额:
$ 45万 - 项目类别: